NEURONASCENT INC has a total of 43 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2006. It filed its patents most often in Australia, China and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are NOVIGA RES AB, AVOSCIENCE LLC and ORGANON IRELAND LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | China | 6 | |
#3 | Israel | 6 | |
#4 | United States | 6 | |
#5 | Canada | 4 | |
#6 | EPO (European Patent Office) | 4 | |
#7 | Republic of Korea | 4 | |
#8 | WIPO (World Intellectual Property Organization) | 4 | |
#9 | Japan | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kelleher-Andersson Judith | 15 |
#2 | Kelleher Andersson Judith | 8 |
#3 | Judith Kelleher-Andersson | 4 |
#4 | Kelleher Anderson Judith | 4 |
#5 | Kelleher-Anderson Judith | 3 |
#6 | Judith Kelleher Andersson | 2 |
#7 | Judith Kelleher Anderson | 1 |
Publication | Filing date | Title |
---|---|---|
AU2013245563A1 | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones | |
AU2013211455A1 | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration | |
CN105287582A | Methods and pharmaceutical compositions for treating down syndrome | |
KR20100040728A | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones | |
WO2008028111A2 | Isolation and differentiation of adult hippocampal arctic ground squirrel neural stem cells | |
AU2006292256A1 | Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration |